Cargando…

Nuclear depletion of RNA-binding protein ELAVL3 (HuC) in sporadic and familial amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis is a progressive fatal neurodegenerative disease caused by loss of motor neurons and characterized neuropathologically in almost all cases by nuclear depletion and cytoplasmic aggregation of TDP-43, a nuclear RNA-binding protein (RBP). We identified ELAVL3 as one of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Diaz-Garcia, Sandra, Ko, Vivian I., Vazquez-Sanchez, Sonia, Chia, Ruth, Arogundade, Olubankole Aladesuyi, Rodriguez, Maria J., Traynor, Bryan J., Cleveland, Don, Ravits, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568872/
https://www.ncbi.nlm.nih.gov/pubmed/34618203
http://dx.doi.org/10.1007/s00401-021-02374-4
_version_ 1784594522996473856
author Diaz-Garcia, Sandra
Ko, Vivian I.
Vazquez-Sanchez, Sonia
Chia, Ruth
Arogundade, Olubankole Aladesuyi
Rodriguez, Maria J.
Traynor, Bryan J.
Cleveland, Don
Ravits, John
author_facet Diaz-Garcia, Sandra
Ko, Vivian I.
Vazquez-Sanchez, Sonia
Chia, Ruth
Arogundade, Olubankole Aladesuyi
Rodriguez, Maria J.
Traynor, Bryan J.
Cleveland, Don
Ravits, John
author_sort Diaz-Garcia, Sandra
collection PubMed
description Amyotrophic lateral sclerosis is a progressive fatal neurodegenerative disease caused by loss of motor neurons and characterized neuropathologically in almost all cases by nuclear depletion and cytoplasmic aggregation of TDP-43, a nuclear RNA-binding protein (RBP). We identified ELAVL3 as one of the most downregulated genes in our transcriptome profiles of laser captured microdissection of motor neurons from sporadic ALS nervous systems and the most dysregulated of all RBPs. Neuropathological characterizations showed ELAVL3 nuclear depletion in a great percentage of remnant motor neurons, sometimes accompanied by cytoplasmic accumulations. These abnormalities were common in sporadic cases with and without intermediate expansions in ATXN2 and familial cases carrying mutations in C9orf72 and SOD1. Depletion of ELAVL3 occurred at both the RNA and protein levels and a short protein isoform was identified, but it is not related to a TDP-43-dependent cryptic exon in intron 3. Strikingly, ELAVL3 abnormalities were more frequent than TDP-43 abnormalities and occurred in motor neurons still with normal nuclear TDP-43 present, but all neurons with abnormal TDP-43 also had abnormal ELAVL3. In a neuron-like cell culture model using SH-SY5Y cells, ELAVL3 mislocalization occurred weeks before TDP-43 abnormalities were seen. We interrogated genetic databases, but did not identify association of ELAVL3 genetic structure with ALS. Taken together, these findings suggest that ELAVL3 is an important RBP in ALS pathogenesis acquired early and the neuropathological data suggest that it is involved by loss of function rather than cytoplasmic toxicity. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00401-021-02374-4.
format Online
Article
Text
id pubmed-8568872
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-85688722021-11-08 Nuclear depletion of RNA-binding protein ELAVL3 (HuC) in sporadic and familial amyotrophic lateral sclerosis Diaz-Garcia, Sandra Ko, Vivian I. Vazquez-Sanchez, Sonia Chia, Ruth Arogundade, Olubankole Aladesuyi Rodriguez, Maria J. Traynor, Bryan J. Cleveland, Don Ravits, John Acta Neuropathol Original Paper Amyotrophic lateral sclerosis is a progressive fatal neurodegenerative disease caused by loss of motor neurons and characterized neuropathologically in almost all cases by nuclear depletion and cytoplasmic aggregation of TDP-43, a nuclear RNA-binding protein (RBP). We identified ELAVL3 as one of the most downregulated genes in our transcriptome profiles of laser captured microdissection of motor neurons from sporadic ALS nervous systems and the most dysregulated of all RBPs. Neuropathological characterizations showed ELAVL3 nuclear depletion in a great percentage of remnant motor neurons, sometimes accompanied by cytoplasmic accumulations. These abnormalities were common in sporadic cases with and without intermediate expansions in ATXN2 and familial cases carrying mutations in C9orf72 and SOD1. Depletion of ELAVL3 occurred at both the RNA and protein levels and a short protein isoform was identified, but it is not related to a TDP-43-dependent cryptic exon in intron 3. Strikingly, ELAVL3 abnormalities were more frequent than TDP-43 abnormalities and occurred in motor neurons still with normal nuclear TDP-43 present, but all neurons with abnormal TDP-43 also had abnormal ELAVL3. In a neuron-like cell culture model using SH-SY5Y cells, ELAVL3 mislocalization occurred weeks before TDP-43 abnormalities were seen. We interrogated genetic databases, but did not identify association of ELAVL3 genetic structure with ALS. Taken together, these findings suggest that ELAVL3 is an important RBP in ALS pathogenesis acquired early and the neuropathological data suggest that it is involved by loss of function rather than cytoplasmic toxicity. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00401-021-02374-4. Springer Berlin Heidelberg 2021-10-07 2021 /pmc/articles/PMC8568872/ /pubmed/34618203 http://dx.doi.org/10.1007/s00401-021-02374-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Paper
Diaz-Garcia, Sandra
Ko, Vivian I.
Vazquez-Sanchez, Sonia
Chia, Ruth
Arogundade, Olubankole Aladesuyi
Rodriguez, Maria J.
Traynor, Bryan J.
Cleveland, Don
Ravits, John
Nuclear depletion of RNA-binding protein ELAVL3 (HuC) in sporadic and familial amyotrophic lateral sclerosis
title Nuclear depletion of RNA-binding protein ELAVL3 (HuC) in sporadic and familial amyotrophic lateral sclerosis
title_full Nuclear depletion of RNA-binding protein ELAVL3 (HuC) in sporadic and familial amyotrophic lateral sclerosis
title_fullStr Nuclear depletion of RNA-binding protein ELAVL3 (HuC) in sporadic and familial amyotrophic lateral sclerosis
title_full_unstemmed Nuclear depletion of RNA-binding protein ELAVL3 (HuC) in sporadic and familial amyotrophic lateral sclerosis
title_short Nuclear depletion of RNA-binding protein ELAVL3 (HuC) in sporadic and familial amyotrophic lateral sclerosis
title_sort nuclear depletion of rna-binding protein elavl3 (huc) in sporadic and familial amyotrophic lateral sclerosis
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568872/
https://www.ncbi.nlm.nih.gov/pubmed/34618203
http://dx.doi.org/10.1007/s00401-021-02374-4
work_keys_str_mv AT diazgarciasandra nucleardepletionofrnabindingproteinelavl3hucinsporadicandfamilialamyotrophiclateralsclerosis
AT koviviani nucleardepletionofrnabindingproteinelavl3hucinsporadicandfamilialamyotrophiclateralsclerosis
AT vazquezsanchezsonia nucleardepletionofrnabindingproteinelavl3hucinsporadicandfamilialamyotrophiclateralsclerosis
AT chiaruth nucleardepletionofrnabindingproteinelavl3hucinsporadicandfamilialamyotrophiclateralsclerosis
AT arogundadeolubankolealadesuyi nucleardepletionofrnabindingproteinelavl3hucinsporadicandfamilialamyotrophiclateralsclerosis
AT rodriguezmariaj nucleardepletionofrnabindingproteinelavl3hucinsporadicandfamilialamyotrophiclateralsclerosis
AT traynorbryanj nucleardepletionofrnabindingproteinelavl3hucinsporadicandfamilialamyotrophiclateralsclerosis
AT clevelanddon nucleardepletionofrnabindingproteinelavl3hucinsporadicandfamilialamyotrophiclateralsclerosis
AT ravitsjohn nucleardepletionofrnabindingproteinelavl3hucinsporadicandfamilialamyotrophiclateralsclerosis